Fangping Chen
Impact in
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research
- Immunology top 10%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
Papers in
- Hematology 13
- Acute Myeloid Leukemia Research 5
- Immunology 14
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 4
- Immune Response and Inflammation 4
- Journals
- Scientific Reports (2 papers)Cancer Letters (2 papers)Thrombosis Research (2 papers)Acta Biochimica et Biophysica Sinica (2 papers)Blood (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Fangping Chen
46 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 107
- Clinical Biochemistry 159
- Immunology 406
- Hematology 142
- Cancer Research 186
- Molecular Biology 690
Countries citing papers authored by Fangping Chen
This map shows the geographic impact of Fangping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangping Chen more than expected).
Fields of papers citing papers by Fangping Chen
This network shows the impact of papers produced by Fangping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangping Chen. The network helps show where Fangping Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fangping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2021 | 14 | |
| 6 | 2020 | 29 | |
| 7 | 2020 | 3 | |
| 8 | 2019 | 235 | |
| 9 | 2019 | 32 | |
| 10 | 2018 | 1 | |
| 11 | 2016 | 2 | |
| 12 | 2015 | 13 | |
| 13 | 2014 | 21 | |
| 14 | 2014 | 5 | |
| 15 | 2013 | 24 | |
| 16 | 2012 | 3 | |
| 17 | 2009 | 25 | |
| 18 | 2009 | 12 | |
| 19 | 2009 | 6 | |
| 20 | 2006 | 9 |
About Fangping Chen
Fangping Chen is a scholar working on Hematology, Immunology, Clinical Biochemistry, Cancer Research and Molecular Biology, having authored 50 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Inflammasome and immune disorders (5 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), RNA Interference and Gene Delivery (4 papers), DNA and Nucleic Acid Chemistry (4 papers), Epigenetics and DNA Methylation (4 papers), Immune Response and Inflammation (4 papers) and Advanced Glycation End Products research (4 papers). The work is most often cited by research in Clinical Biochemistry (159 citations), Immunology (406 citations), Hematology (142 citations), Cancer Research (186 citations) and Molecular Biology (690 citations). Fangping Chen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xinyu Yang, Ben Lü, Haichao Wang, Ben Lv, Yiting Tang, Xianzhong Xiao, Wenjin Li, Xianhui Qiu, Lin Li and Timothy R. Billiar. Their work appears in journals such as Scientific Reports, Cancer Letters, Thrombosis Research, Acta Biochimica et Biophysica Sinica and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.